Prairiewood Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
2,023
+23
+1% +$2.69K 0.07% 67
2026
Q1
$241K Hold
2,000
– – 0.07% 67
2025
Q4
$211K Buy
+2,000
New +$188K 0.07% 68
2024
Q4
– Sell
-2,000
Closed -$227K – 85
2024
Q3
$227K Hold
2,000
– – 0.1% 73
2024
Q2
$248K Buy
+2,000
New +$258K 0.12% 69

Other funds holding MRK

Prairiewood Capital's MRK Position: Q2 2026 in Review

Prairiewood Capital increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $2.69K and bringing the position to 2,023 shares worth $260K. The position accounts for 0.07% of the portfolio, ranked #67.

Prairiewood Capital first reported a position in MRK in Q2 2024 and has held it in 5 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Prairiewood Capital held 2,023 shares of Merck worth $260K as of Q2 2026.
  • Prairiewood Capital bought 23 Merck shares in Q2 2026, an estimated $2.69K.
  • Merck made up 0.07% of Prairiewood Capital's portfolio in Q2 2026, its #67 holding.
  • Prairiewood Capital first reported a position in Merck in Q2 2024 and has held it in 5 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Prairiewood Capital's 13F filing for Q2 2026, filed 28 Jul 2026.